Status | Study |
Completed |
Study Name: 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) Condition: Leukemia Date: 2007-06-05 Interventions: Drug: 2-CdA 12 mg/m^2/day by v |
Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2006-12-04 Interventions: Drug: alvocidib Given IV |
Completed |
Study Name: Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias Condition: Hypereosinophilic Syndrome Chronic Eosinophilic Leukemia (CEL) Date: 2006-01-12 Interventions: Drug: STI571 |
Completed |
Study Name: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndromes Eosinophilic Gastroenteritis Date: 2005-12-15 Interventions: Drug: Mepolizumab 10mg/kg (max 750 ml) once a month for 3 months |
Completed |
Study Name: Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Condition: Acute Myeloid Leukemia Myelodysplastic Syndromes Agnogenic Date: 2005-11-16 Interventions: Drug: Dasatinib (BMS-354825) 70 mg orally twice daily |
Available |
Study Name: This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES 201956: A Long-term Access Programme for Subjects With Severe Asthma Condition: Hypereosinophilic Syndrome Date: 2005-10-25 Interventions: Drug: Mepolizumab open label investigational product |
Withdrawn |
Study Name: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome Condition: Eosinophilia Hypereosinophilic Syndrome Date: 2005-09-28 Interventions: Drug: Gleevec |
Terminated |
Study Name: A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndrome Date: 2005-09-13 Interventions: Drug: imatinib mesylate Other Name: Gleevec/Glivec |
Completed |
Study Name: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Condition: Hypereosinophilic Syndrome Systemic Mastocytosis Date: 2005-09-13 Interventions: Drug: imatinib mesylate Other Name: STI571 |
Completed |
Study Name: A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers Condition: Chronic Myelogenous Leukemia Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Date: 2005-05-02 Interventions: Drug: Nilotinib |